Answers are grounded in this paper and cite their sources.
A new sphingoglycolipid was isolated from human adenocarcinomas. The glycolipid had a novel ceramide which contained predominantly 4-hydroxysphinganine (phytosphingosine) and a high content of α-hydroxy fatty acids. The structure of the carbohydrate moiety was identified as O-β-galactosyl-(1 → 4)-[O-α-l-fucosyl-(1 → 3)]-O-β-(N-acetyl)glucosaminosyl-(1 → 3)-O-β-galactosyl-(1 → 4)-glucose, which was identical with that of lacto-N-fucopentaose III (Kobata, A., and Ginsburg, V., J. Biol. Chem., 244, 5496 (1969)). The precipitating antibody against this glycolipid was produced in rabbit, the antiserum was allowed to react specifically with this glycolipid but not with Lewis a or Lewis b glycolipid, and the precipitin reaction was inhibited by lacto-N-fucopentaose III.
No takes yet. Share an insight, caveat, or question.
Yang et al. (1971) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: